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Abstract
Objective—To examine the distribution of 
insulin like growth factor«1 (IGF-1) recep­
tors and the biological response to IGF-1 
stimulation in articular cartilage of 
normal mouse knee joints andi arthritic 
joints taken at various stages of experi­
mentally induced arthritis.
Methods—In situ IGF-1 receptor ex­
pression and responsiveness to IGF-1 
stimulation were examined in murine 
articular cartilage at different phases in 
two models of experimentally induced 
arthritis. IGF-1 receptor expression was 
visualised in joint sections with the use o f  
anti-IGF-1 receptor antibodies and quan­
tified by confocal laser scanning micro­
scopy. Chondrocyte proteoglycan (PG) 
synthesis was measured by incorporation 
of 35S-suIphate,
Results—In control cartilage, the majority 
of IGF-1 receptors were found on chon­
drocytes localised in the middle and 
deeper zones of the cartilage, whereas 
receptor expression in surface zone chon­
drocytes was very low. During culture o f  
normal articular cartilage, IGF-1 was able 
to maintain chondrocyte PG synthesis at 
the in vivo level. Concurrently with the 
development of arthritis, cartilage lost its 
capacity to react to IGF-1, but IGF-1 
stimulation recovered when the inflam­
matory response waned. Shortly after 
induction of arthritis, IGF-1 receptor 
expression initially declined, but it had 
returned to normal levels by day 1 and 
remained increased thereafter.
Conclusion—The distribution of IGF-1 
receptor expression in the different zones 
of normal articular cartilage reflects 
IGF-1 stimulation and metabolic activity 
of chondrocytes in these layers. This 
correlation is disturbed in arthritic carti­
lage, suggesting inadequate or overruled 
signalling.
{AnnRhewn Dis 1995; 54: 645-653)
Destruction of articular cartilage is a 
prominent feature of inflammatory joint 
diseases such as rheumatoid arthritis (RA).1 
The mechanism underlying tissue damage 
remains largely unknown. There is compelling
evidence that products secreted by inflam­
matory cells, synovia] lining cells, or chondro­
cytes themselves are responsible for loss of 
proteoglycans (PGs), denaturation of collagen, 
and chondrocyte death. The initial deterior­
ation of the cartilage matrix is probably caused 
by disturbance of the equilibrium between 
synthesis and degradation of matrix PGs,2"1 It 
has been demonstrated that mediators such as 
interleukin-1 (IL-I) and tumour necrosis 
factor (TNF) are important inhibitors of chon­
drocyte PG synthesis, IL~1 being more potent 
than TNF. Furthermore, evidence is accumu­
lating that diese cytokines play a crucial role in 
the pathogenesis of arthritis.5"13 In addition, 
lack of anabolic signalling might contribute to 
decreased chondrocyte PG synthesis during 
joint inflammation.1'1 15
Insulin like growth factor-1 (IGF-1) is the 
most important growth factor that regulates 
cartilage PG synthesis.1“ 21 During culture, 
IGF-1 is able to maintain cartilage PG 
synthesis at the in vivo level.18'21 Moreover, 
selective elimination of IGF1- 1 from serum or 
synovial fluid with neutralising antibodies 
results in a marked decrease in cartilage PG 
synthesis, enhanced PG breakdown, and pro- 
duction of alternative PG sybtypes.21 21 IGF-1 
regulates the synthesis of PG monomers with 
large dimensions in normal cartilage, whereas 
in arthritic cartilage the absence of induction 
of PG synthesis accompanies the preferential 
synthesis of PG monomers with only small 
dimensions.33 23 This indicates that IGF-1 
non-responsiveness during arthritis also results 
in the production of alternative PG monomers, 
implying that IGF-1 is an essential signal to 
maintain cartilage integrity.
The biological actions of IGF-1 are medi­
ated by high affinity binding to specific cell 
surface receptors, such as the IGF-1 type 1 and 
type 2 receptors.24 20 These receptors differ 
markedly in structure and peptide binding 
specificity.27 In general, IGF-1 binds prefer­
entially with high affinity to the type 1 receptor, 
which is thought to be especially important in 
postnatal growth and development,28 while the 
type 2 receptor is considered to be a regulator 
of the glucose and energy metabolism and 
displays highest affinity for IGF-2.2<) 10 IGF-2 
is almost exclusively a fetal peptide and is 
considered to be particularly associated with 
organogenesis during embryonic 
ment.27 30 The IGF-1 type 1 receptor is a
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heterotetrameric glycoprotein, comprising two 
extracellular a subunits that are responsible for 
ligand binding and two (3 subunits that span 
the cell membrane and contain tyrosine kinase 
activity in their cytoplasmic region.31 32
We reported previously that murine cartilage 
of knee joints at days 1 and 2 after induction 
of experimental arthritis displayed a state of 
non-responsiveness towards IGF-1 stimulation, 
which is not caused by a general impairment of 
die chondrocyte.14 13 This suggests tiiat 
inhibition of chondrocyte PG synthesis as found 
during joint inflammation is caused at least 
partly by a defect in IGF-1 signalling. There is 
little information available on IGF-1 receptor 
expression in normal and diseased cartilage. A 
recent study demonstrated increased IGF-1 
receptor immunolocalisation on chondrocytes 
in human osteoarthritic (OA) cartilage,33 but 
data on arthritic cartilage are lacking.
In the present study we investigated IGF-1 
receptor expression and the responsiveness to 
IGF-1 stimulation, examining patellar cartilage 
from normal and arthritic knee joints in two 
types of experimentally induced arthritis at 
various phases after induction of joint inflam­
mation. The IGF-1 receptor was immuno- 
localised in different zones of the cartilage with 
the use of an antibody against IGF-1 type 1 
receptor and visualised by both conventional 
fluorescence microscopy and confocal laser 
scanning microscopy (GLSM). In addition, 
receptor expression at the chondrocyte cell 
membrane was quantified on the basis of 
digital CLSM images, as described recently*34 
The effect of IGF-1 on chondrocyte PG 
synthesis was measured by incorporation of 
3<5S-sulphate into mouse patellar cartilage.
Materials and methods
A N IM A LS
Female C57 black/6 mice (8-12 weeks old, 
weights 20-25 g) were studied. The animals 
were kept under routine laboratory condi­
tions (21-22CC, relative humidity 60% and a 
12 hour light-dark cycle). They were fed a 
standard commercial pellet diet (RHM, Hope 
Farms, The Netherlands) and were given 
acidified tap water ad libitum.
IN D U C T IO N  OF A RTH RITIS
Arthritis was induced in mouse knee joints by 
two different methods. In the first, it was 
induced by intra-articular injection of yeast 
particles (180 fjLg sterilised zymosan (Sigma, St 
Louis, MO, USA) in pyrogen free saline) to 
right knee joints. This zymosan induced arthritis 
model is characterised by an early polymorpho­
nuclear cell rich exudate in the joint space, loss 
of cartilage PGs, and inhibition of chondrocyte 
PG synthesis. Inflammation subsides within 
one week, and cartilage damage is 
reversible.4 14 In the second method, arthritis 
was induced with an antigen; this antigen 
induced arthritis, developing shortly after intra- 
articular injection of the antigen in previously 
immunised mice, is a more prolonged arthritis 
model than zymosan induced arthritis.4 Mice
were immunised with 100 jmg methylated 
bovine serum albumin (mBSA, Sigma) 
emulsified in Freund’s Complete Adjuvant 
(FCA) (Difco Laboratories, Detroit, MI, USA), 
Four equally large subcutaneous injections were 
given into the flank and footpads of the 
forelimbs. As an additional adjuvant, 2 X 10<} 
heat killed Bordetella pertussis organisms 
(National Institute of Public Health, Bilthoven, 
The Netherlands) were injected intraperi- 
toneally, After seven days, the immunisation was 
boosted with 100 fxg mBSA emulsified in FCA, 
divided over two equally large subcutaneous 
injections in the back. Arthritis was induced at 
day 21 by intra-articular injection of 60 jig 
mBSA in 6 fxl of phosphate buffered saline 
(PBS) into the right knee joint.
The antigen induced arthritis model is 
characterised by an acute synovial inflam­
mation with numerous granulocytes, which 
changes into a chronic type of inflammation 
characterised by mononuclear cells,4 ” In 
common with zymosan induced arthritis, 
antigen induced arthritis is characterised in the 
acute phase of the disease by severe destruction 
of the cartilage matrix and inhibition of 
chondrocyte metabolism.
Left contralateral knee joints received no 
injections, and served as controls. It is known 
from previous studies that the contralateral 
joints show responses to the treatment that do 
not differ from the appearance of joints in 
control animals.
Mice were killed by cervical dislocation at 6, 
12, 24, 48, 72, 96, or 168 hours after induction 
of arthritis and intact patellae were dissected 
from the right arthritic knee joints and left 
contralateral control knee joints. During the 
dissection process, the patellar ligaments were 
cut, but care was taken to leave the cartilage 
fully intact.4 36
JO IN I ' IN FL A M M A T IO N
Joint inflammation was determined during 
different phases of arthritis by measurement of 
y‘,mTc-pertechnetate (°,,mTc) uptake by the knee 
joint. Mice were sedated using chloralhydrate 
injected intrap eritoneally, and <,I,mTc was 
injected subcutaneously in the neck. After 20 
minutes, radioactivity was measured in both 
knees, which were in a fixed position. Joint 
swelling was expressed as the ratio of the l,t,mTc 
uptake in the right to that in the left knee joints
(R:L ratio), a value greater than 1*1 
indicating swelling.
CARTILAGE C U L T U R E S
Patellae were cultured in an RPMI 1640 
medium (Flow Laboratories, Irvine, Scotland) 
containing 2 mmol/1 glutamine, 40 fxg/ml 
gentamycin, 0*1% ultrapure BSA (Sigma), 
with or without addition of 0*25 fxg/ml 
recombinant human IGF-1 (Boehringer, 
Mannheim, Germany). The molarity of 
0*25 |xg/ml IGF-1 is 4*38 X 10 H. All 
incubations were performed over 24 hours in 
24 well cluster dishes at 37°C in a humidified 
atmosphere containing 5% carbon dioxide.
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FR O T E O G L Y C A N  SY N TH ESIS IN V ITR O
Chondrocyte PG synthesis in patellar cartilage 
of control joints and of knee joints during 
different phases of arthritis was measured by 
the incorporation of V*S-sulphate as described 
previously.10 ™ Briefly, cartilage was cultured 
in RPMI 1640 medium containing 0*1% BSA, 
glutamine and gentamycin in the presence of 
6 MBq i5S-sulphate (Na35S 0 4l3 Amersham, 
Buckinghamshire, UK) for two hours at 37aC. 
This was done both immediately after isolation 
of intact patellae to estimate the in vivo level 
of proteoglycan synthesis, and after a 24 hour 
culture period to estimate the level of proteo­
glycan synthesis after culture. Afterwards, 
tissues were washed three times with PBS to 
remove non-incorporated ^S-sulphate. Patel­
lae were subsequently fixed in 96% ethanol and 
decalcified in 5% formic acid for three hours, 
followed by stripping of the articular cartilage 
layer from the remainder of the patellae. The 
patellar cartilage was digested in Lumasolve 
(Perstop Analytical, Oud Beyerland, The 
Netherlands) at 60°C. The quantity of in­
corporated radioactive sulphate in each patella 
was assayed by liquid scintillation counting.
PREPA RA TIO N  O F  T IS S U E  F O R  
IM M U N O H IS T O  C H EM  ISTRY
Patellae were embedded in 8% gelatin white 
(Sigma) in distilled water, frozen in liquid 
nitrogen and cryostat sections of the frozen 
mouse patellae were cut (7 jxm thick) on a 
motor driven Bright cryostat fitted with a 
microtome with a tungsten carbide tipped 
knife at a cabinet temperature of ~-25°Q and 
attached to adhesive tape (Scotch tape 800, 
3M, St Paul, M N ).'1' 41 Sections were kept dry 
over silica gel and stored at -25*C until 
required for further use.
IM M U N O IIIS T O O IIE M IS T  RY
Cryostat sections were fixed for 10 minutes in 
4% paraformaldehyde (Sigma) in PBS, pH 
7-4, and subsequently washed in PBS con­
taining 10% BSA (Sigma), 10% gelatin and 
0-3% glycine (Pharmacia, Upsala, Sweden). 
They were then incubated for 30 minutes at 
37°C in a solution of 2 mg/ml testicular hyal- 
uronidase (Sigma) in PBS to improve antibody 
penetration into the cartilage matrix. There­
after, sections were washed in PBS, incubated 
for 30 minutes in PBS containing 10% fetal 
calf serum and 1% BSA in PBS and then for 
24 hours at 4°C in the presence of the prim a 17 
antibody in a concentration of 5 (xg/ml in PBS 
in the presence of 1% BSA. Polyclonal rabbit 
antihuman type 1 IGF-1 receptor antibody was 
obtained from UBI (New York, NY, USA); it 
recognises mouse type 1 IGF-1 receptor.1,4 r‘ 
Sections were then washed in PBS and in­
cubated with biotinylated goat antirabbit 
secondai7  antibody (Vector Laboratories, 
Burlingame, USA) for one hour in a dilution 
of 1:500 in PBS in the presence of 1% BSA and 
1% normal mouse serum. Thereafter, they 
were washed in PBS and exposed to strep- 
tavidin-fluorescein isothiocyanate (Boeh-
ringer) in a concentration of 5 jxg/ml in PBS. 
Subsequently, the slides were mounted in 
glycerol-phenylenediamine solution (Sigma) to 
prevent fading of the fluorescence, and kept at 
-25°C until evaluation using CLSM. Control 
sections were incubated either with an IgG 
fraction of normal rabbit serum used in the 
same dilution as the primary antibody, or in the 
absence of primary antibody .
k»-4h Sections were subjected to
C : I ,SM E VA I . U A ' I I  O N  A N D  IMA t  Hi ANALYSIS
Immunolabelled cryostat sections were exam­
ined with a Leica CLSM in combination with 
a Leica Flu overt microscope using the 488 11 m 
line of an Argon Krypton laser as described in 
an earlier study.14 The CLSM collects images 
that are almost free from out of focus signals, 
and the system allows optical sectioning of the 
specimen.
optical sectioning and the immunofluor­
escence signal was quantified. Quantification 
of immunofluorescence intensity in the con- 
focal images was determined by area measure­
ment at the chondrocyte periphery.14 To assess 
the contribution of autofluorescence and non­
specific binding, the fluorescence signal in 
sections stained with control non-immune 
serum was also measured.
Chondrocytes were assessed in the deep, 
middle3 and surface zones of the cartilage. The 
average fluorescence intensity was expressed as 
percentage of the mean fluorescence intensity 
of chondrocytes in the control cartilage. 
Statistical evaluation of the experiments was 
performed with the Wilcoxon rank test. A value 
of p less than 5% was considered significant.
R esults
C H O N D R O C Y T E  PC r S Y N T H E S IS  A N D  JO IN T  
IN F L A M M A T IO N
When normal patellae were cultured for 
24 hours in media without serum or growth 
factors, chondrocyte PG synthesis declined to 
approximately 50% of that immediately after 
dissection of the cartilage.14 Culturing cartilage 
for 24 hours in the presence of 0*25 2‘0 |jig/mt 
IG F -1 induced a significant, dose dependent
of chondrocyte PG synthesis 
(fig 1). In all other experiments we used 
0*25 jig/ml IG F -1, which maintained PG syn­
thesis of normal cartilage at in vivo levels, and 
which is close to the physiological concen­
tration of IGF-1 in mouse tissues.21 1,1
Six hours after the onset of zymosan induced 
a r t h r i t i S j  the ex vivo chondrocyte PG synthesis 
remained at the same level as found in control 
cartilage and no enhanced R;L ratio of ,,,,mTc 
uptake, reflecting joint swelling, was observed 
(■fig 2A, B). Within 12 hours of induction of 
arthritis, the ex vivo PG synthesis of arthritic 
cartilage decreased to approximately 80% of 
the levels of WS-sulphate incorporation in 
control cartilage, whereas at 24-72 hours after 
induction incorporation of ^S-sulphate into 
arthritic cartilage was markedly reduced, to 
approximately 50% of the normal PG 
synthesis. Joint swelling was observed within 
12 hours of the induction of zymosan induced
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Figure I In vitro response to IGF-1 stimulation of normal 
( i'3)  and zymosan induced arthritic C'U) articular 
cartilage o f mice: chondrocyte PG synthesis determined by 
55S-sulphatc incorporation either immediately after isolation 
o f the patellae ( t — 0) or after 24 hours culture in media 
containing 0-2'0 ¡xg/ml IGF-1, Data represent the mean 
(SE M ) o f three experiments, expressed as percentage of the 
control value a t t = 0 .
*p< 0'05 compared with control
arthritis, reached a maximum at 24 hours, and 
disappeared at four days after induction 
(fig 2B). At day 4, the inflammatory response 
waned and chondrocyte PG synthesis in the 
arthritic cartilage became restored. Con- 
currently with die development of zymosan 
induced arthritis (reduction of PG synthesis in 
the arthritic cartilage and enhancement of joint 
swelling), the arthritic cartilage lost its capacity 
to respond to IGF-1 in a 24 hour culture 
system (fig 2C), even supraphysiologically high 
concentrations (2*0 |xg/ml) of IGF-1 failing to 
induce stimulation of PG synthesis (fig 1). 
Four days after induction of arthritis, recovery 
of IGF-1 responsiveness was observed in the 
arthritic cartilage (fig 2C).
After antigen induced arthritis, a somewhat 
different response was observed. Significant 
inhibition of PG synthesis in the arthritic 
cartilage was first observed one day after 
induction of arthritis, suppression was more 
pronounced at days 2 and 3, and recovery of 
PG synthesis appeared to be retarded (fig 2A). 
An enhanced R:L ratio of 09mTc uptake was 
noted 24 hours after antigen induced arthritis. 
Maximal joint swelling was reached within 
three to four days after induction of arthritis, 
and swelling began to disappear seven days 
after the induction of arthritis (fig 2B). This is 
consistent with the significantly more pro­
longed form of arthritis represented in the 
antigen induced arthritis model as compared 
with the zymosan induced arthritis model.4 w 
IGF-1 stimulation of chondrocyte PG syn­
thesis in the arthritic cartilage disappeared 
during the manifestation of arthritis in the 
antigen induced arthritis model and was still 
not restored at day 4 (fig 2D). As shown for 
the zymosan induced arthritis model, high 
concentrations of IGF-1 were unable to induce 
stimulation of PG synthesis in the antigen 
induced arthritis model (data not shown).
IM M U N O H IS  T O  C H E M IC A L  L O C A LISA TIO N  OF 
IG F-1  R E C E P T O R  IN  N O R M A L  CA RTILA G E
Conventional fluorescence microscopical 
evaluation of mouse patellar cartilage sections 
stained immunohistochemically to demon­
strate IGF-1 type 1 receptor revealed the 
presence of the IGF-1 receptor in chondro­
cytes within the articular cartilage, whereas 
the cartilage matrix was negative (fig 3A), 
Immunoreactivity was present on the
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Figure 2 Proteoglycan synthesis (measured as incorporation of^S-sulphate) in patellar cartilage immediately after 
isolation o f the cartilage (A) and afterculture for 24 hours in the presence or absence of IG F -1 0*25 jig/ml (C} D); the 
contralateral patellar cartilage was used as control B: Joint swelling, expressed as ratio o f99,nTc uptake in the right and left 
knee joints. Data represent the mean of at least two experiments and are mean (SEM ) of five  patellae in each group.
A y B: □  = zymosan induced arthritis; •  = antigen induced arthritis. C} D: □  = IGF-1; % - n o  IGF-1.
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A
Figure 3 IGF-1 reccptor immunoloealisation in mouse normal patellar cartilage. A : Light m icroscope evaluation of the 
mmunolocalisation of IGF- 1 receptor. Chondrocytes (CH) within the articular cartilage (AC) distinctly stained, bin 
cartilage matrix (CM ) staining negative, Bar represents 21 '1 /xm, B; Light microscope evaluation of control sunning 
with non-inmiune scrum. Background negligible compared with anti-IGF-I receptor miming. Bar represents 2 h i  ¡xm.
C: Confocal laser scanning microscope (C LSM ) evaluation o f the middle optical section through the depth of the 
chondrocyte. The chondrocyte membrane contains intense IGF-1 receptor immunoreactivity (arrow). Bar represents 
.?*5 ¡xm. I): Ovoview (rfinnnu nolocalisation of IGF-1 receptors on chondrocytes located in different zones o f mouse 
cartilage as visualised by CLSM. Chondrocytes located in the middle (m) and deeper (d) zones shozo bright positive 
staining, whereas staining of chondrocytes in the surface zone (s) is similar to background fluorescence. Bar represents 
I '3 ¡xm,
chondrocyte celt surface, but a diffuse intra­
cellular staining was also observed, and diffuse 
autofluorescence was found over the entire 
cartilage area. Background staining in sections 
that were treated with non-immune rabbit 
serum was negligible in comparison with anti- 
IGF-1 receptor staining (fig 3B). With con­
ventional fluorescence microscopy it was 
impossible to determine exact amounts of 
IGF-1 receptor immunoreactivity on the chon­
drocyte plasma membrane. Evaluation with 
CLSM showed that the chondrocyte mem­
brane contained intense IGF-1 receptor 
immunoreactivity (fig 3C), and allowed for 
exact measurement of non-immune serum and 
aIGF-1 receptor fluorescence signal (fig 3D). 
Non-specific fluorescence and auto- 
fluorescence caused a constant level of back­
ground fluorescence in all cartilage layers 
which was consistent in all experiments. IGF-1 
receptor immunostaining on the chondrocyte 
cellular membrane was observed in particular 
in chondrocytes of the middle and deeper 
zones of the cartilage, whereas chondrocytes in 
the surface zone did not show any significant 
specific staining for these receptors (fig 3D)* 
Chondrocytes in surface zones displayed a
fluorescence intensity similar to the 
background fluorescence.
IM M U N O H 1STO C H K M 1G A 1. I .OCA1 .IS ATI ON OF 
IGF-1 RLiCKPTOR IN A R T H R IT IC  CARTIJ.AUH
Zymosan induced arthritis. Quantification of 
the fluorescence intensity on chondrocyte cell 
membranes revealed that, at six hours after 
induction of arthritis, chondrocytes in the 
deeper zones still displayed normal fluor­
escence intensity, while those located in the 
middle zone exhibited a reduced fluorescence 
signal compared with chondrocytes in the 
middle zone of control cartilage (fig 4A). 
Within 12 hours of induction of arthritis, fluor­
escence intensity in both middle and deeper 
zones was significantly reduced compared with 
that in control cartilage (figs 4A, 5A). At 
24 hours after induction of arthritis, the same 
low levels of immunofluorescence staining 
were found, and at 48 hours, chondrocytes 
located in both middle and deeper zones 
showed IGF-1 receptor immunoreactivity 
similar to that in control cartilage; this 
remained constant until the end of the period 
of study (fig 4A).
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Antigen induced arthritis. In contrast with 
findings in patellae after zymosan induced 
arthritis, significant low immunoreactivity was 
already evident six hours after induction of 
arthritis by antigen (figs 4B, 5B). Surprisingly, 
24 hours after antigen induction of arthritis, 
IGF-1 receptor staining had returned to 
normal levels in chondrocytes of both middle 
and deep layers. From this phase of the 
arthritis onwards, immunoreactivity in chon­
drocytes in the deeper zones of the cartilage 
remained constant at die level of that in control 
cartilage. Chondrocytes in the middle zones 
showed a slight but not significant increase in 
fluoresence intensity. At day 7 after induction 
of arthritis, IGF-1 receptor immunoreactivity 
in chondrocytes of both zones had returned to 
the levels found in control cartilage.
Discussion
IGF-1 is known 
regulation of
to have a key role in the 
chondrocyte biosynthetic
functions,16 1H~2{ and lack of anabolic signalling 
during arthritis14 33 (fig 1) may contribute to 
cartilage destruction. In the present study we 
have shown that distribution patterns of IGF-1 
receptor expression in the different zones of 
normal cartilage may reflect IGF-1 stimulation 
and metabolic activity of chondrocytes in these 
layers. Concurrently with the development of 
arthritis, cartilage lost its capacity to react to 
IGF-1, but when the inflammatory response 
was waning, IGF-1 stimulation had recovered. 
Shortly after induction of experimental arth­
ritis a clear decrease in IGF-1 receptor expres­
sion was observed, whereas in later phases of 
arthritis, receptor expression returned rapidly 
to normal levels.
In a previous study we showed that non­
responsiveness to IGF-1 stimulation occurred 
at days 1 and 2 after induction of experimental 
arthritis.1*1 These results, together with those 
outlined above, indicate that the phenomenon 
of IGF-1 non-responsiveness is highly corre­
lated with the severity of arthritis.'1 The early
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Figure 5 IGF-1 receptor inimunolocalisation in cryostat sections of surface (s)> middle (in) and deep (d) zones of mouse 
patellar cartilage at various phases of either zymosan induced arthritis (A) or antigen induced arthritis (B ), visualised by 
confocal laser scanning microscopy. Bars represent. I \? ¡xm. A: 'Twelve hours after zymosan induced arthritis; weak 
IGF-1 receptor inimunoreactivity in zones s, m> and d, compared with cartilage from control joints. B: Six hours after the 
onset o f antigen induced arthritis; km  IGF-1 receptor immunoreactivity in zones s, ms and d, compared with the 
fluorescence intensity found in control cartilage.
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start of IGF-1 non-responsiveness in zymosan 
induced arthritis, and the later recovery in 
antigen induced arthritic cartilage, are con­
sistent with the early onset of zymosan induced 
arthritis and the more prolonged inflammation 
in antigen induced arthritis.
In our analysis of IGF-1 receptor expression, 
CLSM optical sectioning of sections after 
immunolocalisat;ion of IGF-l receptor allowed 
accurate localisation and quantification of the 
immunoreactivity in the chondrocyte cell 
membrane.34 The majority of IGF-1 receptor 
immunoreactivity was localised in chondro­
cytes of the middle and deeper zones of control 
cartilage, while it was very low in chondrocytes 
of the surface zone (fig 5). It is known that 
chondrocytes in the middle and deeper zones 
of human, pig, and bovine cartilage display 
greatest metabolic activity, whereas the meta­
bolic activity of superficial chondrocytes is very 
low.50 53 On the basis of our data it may be 
concluded that differences in IGF-1 receptor 
expression in the cartilage layers are correlated 
with the heterogeneity in IGF-1 stimulation 
and activity of the chondrocytes in these layers.
Data also exist that indicate that alterations 
in chondrocyte metabolism under patho­
physiological conditions also are not uniform 
in the different zones.54 55 In human OA 
cartilage, high levels of IGF-1 and IGF-1 
mRNA have been described, especially in 
chondrocytes located in clones at the surface 
zone.56 Furthermore, it has been shown that 
human OA cartilage was abundantly stained 
for IGF-1 receptor in die upper two thirds of 
the cartilage.33 It should be noted that PG 
synthesis is at a high level in osteoarthritic 
cartilage, in contrast with arthritic cartilage.
In view of our data, it may be questioned 
which factors account for the decrease in 
IGF-1 receptor expression shortly after induc­
tion of arthritis. Under normal conditions, 
IGF-1 receptor expression is regulated on the 
basis of receptor occupancy: receptors are 
rapidly internalised and down regulated after 
IGF-1 binding.57 5H It remains a matter of 
speculation whether and how inflammatory 
mediators are involved in the reduction of 
IGF-1 receptors during the early stages of 
arthritis. Many plasma membrane receptors 
such as antigen binding molecules, adhesion 
molecules, and cytokine receptors have been 
reported to decrease in number during inflam­
mation, by shedding.50 Porteu et a l(}{) suggested 
that shedding of TNF receptors on activated 
polymorphonuclear cells might be the result of 
cleavage by proteases released from inflam­
matory cells or by chondrocytes them­
selves.61"63 We have shown previously that 
oxygen radicals produced by cells in the 
inflamed synovium are unlikely to be involved 
because they were unable to damage IGF-1 
receptors in vitro.64 The early loss of receptors 
coincides with a rapid decline in proteoglycan 
content, which may indicate that it is caused 
by the same proteolytic enzymes released into 
the extracellular matrix cartilage.
The apparent discrepancy between low 
levels of IGF-1 receptor expression in cartilage 
from joints in early stages of arthritis and
normal responses to IGF-1 at these phases of 
arthritis may be explained by the time needed 
for the translation of IGF-1 receptor binding 
into changes of chondrocyte PG synthesis. A 
lag phase of approximately eight hours has 
been reported.05 Moreover, PG synthesis is 
measured after a 24 hour culture period, and 
it is likely that in these early stages of arthritis 
the chondrocytes may recover during culture 
and upregulate the amount of IGF-1 receptors 
on their cell membranes* At present, recovery 
of receptor expression after culture is under 
investigation in our laboratory, and prelimi­
nary data have shown a recovery of receptor 
expression in cartilage at early stages of 
arthritis. In addition, we are now analysing 
potential changes in mRNA expression of the 
IGF-1 receptor during early phases of arthritis, 
using polymerase chain reaction technology.
Our observation that, at later stages of 
arthritis, amounts of IGF-1 receptors rapidly 
returned to normal levels, while inhibition of 
PG synthesis continued, suggest that at this 
phase of arthritis the IGF-1 signal is overruled 
by suppressive mediators generated by the 
inflamed synovium. Otherwise, the type I 
receptor might be masked or damaged by 
agents produced by the inflamed synovium, 
preventing correct binding of IGF-1. Alterna­
tively, but speculatively, the IGF-1 receptors 
present on the chondrocyte cell surface during 
later phases of arthritis may have a defective 
molecular structure, being therefore unable to 
exhibit normal biological functions.
Taking into consideration our present results
we sueand those of previous studies,1'1 ^ 
that IGF-1 non-responsiveness may play a part 
in perpetuating inhibition of chondrocyte PG 
synthesis. Moreover, non-responsiveness of 
arthritic chondrocytes is not restricted to 
IGF-1, but also extends to a range of other 
growth factors: basic fibroblast growth factor* 
platelet derived growth factor, epidermal 
growth factor, or transforming growth factor pi, 
in the presence or absence of IGF-1, were 
unable to stimulate chondrocyte PG synthesis 
during early and later phases of arthritis.™ It 
remains unclear which mediators are involved 
in IGF-1 non-responsiveness during experi­
mentally induced arthritis. Intra-artieukir 
injection olTL-1 into mouse knee joints caused 
inhibition of chondrocyte PG synthesis and 
enhanced PG breakdown, but did not induce
and in
cartilage obtained from arthritic knee joints 
and cultured with anti-IL-1 neutralising anti­
bodies, the state of IGF-1 non-responsiveness 
was not completely abrogated.M However, 
normal IGF-1 responsiveness was observed in- 
arthritic cartilage when anti-IL-1 treatment 
was started in vivo, before induction of 
arthritis. These observations imply that IL-1 
plays an indirect or subordinate part in IGF-1 
non-responsiveness. Alternatively, increased 
IGF-1 binding protein (IGFBP) production 
may cause IGF-1 non-responsiveness during 
experimentally induced arthritis.0” f,M Do re et al 
reported that, during osteoarthritis, articular 
chondrocytes produce increased levels of 
IGFBP.33 In our experimental design,
IGF-1 non-responsiveness,7 **t,v
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decreased IGF-1 bioactivity could occur when 
tissue IGFBP production is increased. How­
ever, we found IGF-1 non-responsiveness even 
at high IGF-1 concentrations, making IGFBP 
overproduction an unlikely explanation for the 
lack of IGF-1 response during inflammation.
In conclusion, we have shown that distri­
bution patterns of IGF-1 receptor expression 
in the different zones of normal cartilage reflect 
IGF-1 stimulation and metabolic activity of 
chondrocytes in these layers. However, our 
data do not reveal a straightforward correlation 
between receptor expression and biological 
response of chondrocytes from arthritic 
cartilage» The present study thus seems to 
imply that caution should be taken in drawing 
conclusions from receptor expression investi­
gations without evaluating the biological 
responses triggered by receptor binding.
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